Bone marrow micrometastases in 109 breast cancer patients: Correlations with clinical and pathological features and prognosis

Breast Cancer Research and Treatment

Volumn 42, Issue 1, 1997, Pages 23-30

  Molino, Annamaria ^a,d   Pelosi, Giuseppe ^b   Turazza, Monica ^a   Sperotto, Loris ^a   Bonetti, Andrea ^a   Nortilli, Rolando ^a   Fattovich, Giovanni ^b   Alaimo, Cristoforo ^b   Piubello, Quirino ^b   Pavanel, Flavia ^a   Micciolo, Rocco ^c   Cetto, Gian Luigi ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b Azienda Ospedaliera   (Italy)

^c UNIVERSITY OF TRENTO   (Italy)

^d Divisione Clinicizzata di Nefrologia   (Italy)

Author keywords

Bone marrow; Breast cancer; Micrometastases; Prognosis

Indexed keywords

MONOCLONAL ANTIBODY; TUMOR ANTIGEN;

ARTICLE; ASPIRATION; BONE MARROW CELL; BONE MARROW METASTASIS; BREAST CANCER; FEMALE; HUMAN; IMMUNOASSAY; LEUKOCYTE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ANTIBODIES, MONOCLONAL; BONE MARROW NEOPLASMS; BREAST NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; PROGNOSIS; RECEPTORS, ESTROGEN;

EID: 8044237715     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005747711084     Document Type: Article

References (34)

1. Harris JR, Morrow M, Bonadonna G: Cancer of the breast. In: De Vila VT, Hellman S, Rosenberg SA (eds) Cancer. Principles and Practice of Oncology, (ed 4). JB Lippincott, Philadelphia, 1993, chapter 40: 1264-1332
2. Coombes RC: The staging of human breast cancer: Physical staging techniques. In: Coombes RC, Powles YJ, Ford HT, Gazet JC (eds) Breast Cancer Management: The Experience of the Combined Breast Clinic, St. George's Hospital and the Royal Marsden Hospital. Academic Press, London, 1981, 77-95
3. Coombes RC, Dearmaley DP, Buckman R: Detection of bone metastases in patients with breast cancer. Invasion Metastasis 2: 177-184, 1982
4. McNeil BJ, Pace PD, Gray EB, Adelstein SJ, Wilson RE: Preoperative and follow-up bone scans in patients with primary carcinoma of the breast. Surg Gynecol Obstet 147: 745-748, 1978
5. Salvadori B, Squicciarini P, Rovini D, Orefice S, Andreola S, Rilke F, Barletta L, Menard S, Colnaghi MI: Use of monoclonal antibody MBr1 to detect micrometastases in bone marrow specimens of breast cancer patients. Eur J Cancer 26(8): 865-867, 1990
6. Kirk SJ, Cooper GG, Hoper M, Watt PCH, Roy AD, Odling-Smee W: The prognostic significance of marrow micrometastases in women with early breast cancer. Eur J Surg Oncol 16: 481-485, 1990
7. Dearnaley DP, Ormerod MG, Sloane JP: Micrometastases in breast cancer: Long-term follow-up of the first patient cohort. Eur J Cancer 27(3): 236-239, 1991
8. Mansi JL, Easton D, Berger U, Gazet JC, Ford HT, Dearnaley D, Coombes RC: Bone marrow micrometastases in primary breast cancer: Prognostic significance after 6 years' follow-up. Eur J Cancer 27(12): 1552-1555, 1991
9. Cote RJ, Rosen PP, Old LJ, Osborne MP: Detection of bone marrow micrometastases in patients with early-stage breast cancer. Diagn Oncol 1: 37-42, 1991
10. Osborne MP: Breast cancer micrometastases in bone marrow detected by fluorescein-labelled monoclonal antibodies: predictor of early relapse. Abstract. Conference on cancer micrometastasis: biology, methodology, and clinical significance. Bethesda (USA), June 25, 1992
11. Cote RJ: Detection and prognostic significance of occult bone marrow micrometaslases in patients with early stage breast carcinoma. Abstract. Conference on cancer micrometastasis: Biology, Methodology, and clinical significance. Bethesda (USA), June 25, 1992
12. Schlimok F, Lindemann F, Holzmann K, Witte J, Renner D, Riethmuller G: Prognostic significance of disseminated tumor cells detected in bone marrow of patients with breast and colorectal cancer: a multivariate analysis. Abstract. Conference on cancer micrometastasis: biology, methodology, and clinical significance. Bethesda (USA), June 25, 1992
13. Diel IJ, Kaufmann M, Goerner R, Costa SD, Kaul S, Bastert G: Detection of tumor cells in bone marrow of patients with primary breast cancer: a prognostic factor for distant metastasis. J Clin Oncol 10(10): 1534-1539, 1992
14. Merkle E, Henke A, Bahr I, Buhner M, Lang N: Tumor cell detection in bone marrow of primary breast cancer patients. Abstract. 18th International Congress of Chemotherapy. Stockholm Sweden pg 322, June 27-July 2, 1993
15. Harbeck N, Untch M, Pache L, Eiermann W: Tumor cell detection in the bone marrow of breast cancer patients at primary therapy: results of a 3-year median follow-up. Br J Cancer 69: 566-571, 1994
16. Menard S, Squicciarini P, Luini A, Sacchini V, Rovini D, Tagliabue E, Veronesi P, Salvadori B, Veronesi U, Colnaghi MI: Immunodetection of bone marrow micrometastases in breast carcinoma patients and its correlation with primary tumor prognostic features. Br J Cancer 69: 1126-1129, 1994
17. Berger IJ, Bettelheim R, Mansi JL, Easton D, Coombes C, Neville M: The relationship between micrometastases in the bone marrow, histopathologic features of the primary tumor in breast cancer and prognosis. Am J Clin Pathol 90: 1-6, 1988
18. Molino A, Micciolo R, Turazza M, Bonetti F, Piubello Q, Corgnati A, Sperotto L, Martignoni G, Bonetti A, Nortilli R, Castelli P, Rodella S, Capelli P, Manfrin E, Pelosi Cetto GL: Estrogen receptors in 699 primary breast cancer: A comparison of immunohistochemical and biochemical methods. Breast Cancer Res Treat 34: 221-228, 1995
19. Tagliabue E, Porro G, Barbanti P, Della Torre G, Menard S, Rilke F, Colnaghi MI: Improvement of tumor cell detection using a pool of monoclonal antibodies. Hybridoma 5: 107-115, 1986
20. Molino A, Colombatti M, Bonetti F, Zardini M, Pasini F, Perini A, Pelosi G, Tridente G, Veneri D, Cetto GL: A comparative analysis of three different techniques for the detection of breast cancer cells in bone marrow. Cancer 67(4): 1033-1036, 1991
21. Pelosi G, Bresaola E, Manfrin E, Rodella S, Schiavon I, Iannucci A: Immunocytochemical detection of cell proliferation-related antigens in cytologic smears of human neoplasms using PC10, reactive with proliferating cell nuclear antigen (PCNA) and Ki67: a comparative study. Arch Pathol Lab Med 118: 510-516, 1994
22. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481, 1958
23. Cox DR: Regression model and life tables (with discussion). J Roy Stat Soc (B) 34: 187-220, 1972
24. Breslow N: Covariance analysis of censored survival data. Biometrics 30: 89-99, 1974
25. Dixon WJ: BMDP statistical software. University of California Press, Berkeley 1988
26. Mansi JL, Berger U, Easton D, McDonnell T, Redding WH, Gazet JC, McKinna A, Powles T, Coombes RC: Micrometastases in bone marrow in patients with primary breast cancer: evaluation as an early predictor of bone metastases. Br Med J 295: 1093, 1987
27. Diel I, Kaufmann M, Krempien B, Kaul S, Gorner R, Costa S, Bastert G: Immunocytochemical detection of tumor cells in bone marrow in patients with primary breast cancer. Br J Cancer 62 (suppl 12): 3, 1990
28. Osborne MP, Wong GY, Cole RJ, Liu J, Potter C, Killackey D, Old LJ, Rosen PP: Breast cancer micrometastases in bone marrow: detection by fluorescein-labeled monoclonal antibodies predicts early relapse. Abstract. Proceedings of ASCO 10: A53, 1991
29. Menard S: Bone marrow micrometastases in breast cancer: correlation with the tumor biology. Conference on cancer micrometastasis: biology, metodology, and clinical significance. Abstract. Bethesda (USA), June 25, 1992
30. Cote RJ, Rosen PP, Lesser ML, Old LJ, Osborne MP: Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases. J Clin Oncol 9(10): 1749-1756, 1991
31. Diel LJ, Kaufmann M, Solomayer EF, Costa SD, Gruber-Holtmann B, Kaul S, Bastert G: Micrometastatic tumor cells in bone marrow versus nodal status in breast cancer-impact on prognosis in patients with primary breast cancer. Abstract. Proceedings of ASCO 14: 110, 1995
32. Singhal H, Cote RJ, Poller C, Osborne MP: Bone marrow micrometastases in breast cancer: relationship to local-regional disease status. Abstract. Proceedings of ASCO 13: A215, 1994
33. Ross AA, Cooper BW, Lazarus HM, Mackay W, Moss TJ, Ciobanu N, Tallman MS, Kennedy MJ, Davidson NE, Sweet D, Winter C, Akard L, Jansen J, Copelan E, Meagher RC, Herzig RH, Klumpp TR, Kahn DG, Warner NE: Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques. Blood 82(9): 2605-2610, 1993
34. Brugger W, Bross KJ, Glatt M, Weber F, Mertelsmann R, Kanz L: Mobilization of tumor cells and hematopoictic progenitor cells into peripheral blood of patients with solid tumors. Blood 83(3): 636-640, 1994